Assays and applications in warfarin metabolism: what we know, how we know it and what we need to know

By Jones Drew R   Miller Grover P  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 7, 2011-07 ,pp. : 857-874

Informa Healthcare

Access to resources Recommend Favorite

Editorials (Stem Cell Tourism in the Era of Personalized Medicine: What We Know, and What We Need to Know)

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 2, 2012-06 ,pp. : 106-110

Bentham Science Publishers

Access to resources Recommend Favorite

Idarucizumab: What Should We Know?

By  

Current Drug Targets, Vol. 19, Iss. 1, 2018-01 ,pp. : 81-88

Bentham Science Publishers

Access to resources Recommend Favorite

ACE Inhibitors in Heart Failure: What More Do We Need to Know?

By Demers Catherine   Mody Anita   Teo Koon K.   McKelvie Robert S.  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 6, 2005-01 ,pp. : 351-359

Adis International

Access to resources Recommend Favorite

What do we know about the entry of Neisseria meningitidis into the meninges?

By Nassif X.   Pujol C.   Tinsley C.   Morand P.   Eugene E.   Marceau M.   Perrin A.   Pron B.   Taha M.-K.  

European Journal of Medicinal Chemistry, Vol. 95, Iss. 4, 1997-10 ,pp. : 219-235

Elsevier

Access to resources Recommend Favorite